Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2006;55:308-309; doi:10.1136/gut.2005.076075
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology.

COMMENTARY

Crohn's disease

Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health

S Schreiber

Correspondence to:
Correspondence to:
Professor S Schreiber
Institute for Clinical Molecular Biology and Department for General Internal Medicine, University-Hospital-Schleswig-Holstein, Schittenhelmstr 12, 24105 Kiel, Germany; s.schreiber@ikmb.uni-kiel.de


The increased intestinal permeability in Crohn’s disease is associated with the presence of variants in the CARD15 gene that are regarded as causative for Crohn’s disease, suggesting a genetic rather than an environmental background for intestinal barrier dysfunction in Crohn’s disease

Keywords: intestinal barrier function; intestinal permeability; inflammatory bowel disease; CARD15/NOD2 mutation; gene analysis; Crohn’s disease; colitis; innate immunity

The first 150 words of the full text of this article appear below.

The association of sequence variants in the capsase recruitment domain family, member 15 (CARD15) gene that encodes for the protein nucleotide binding oligomerisation domain 2 (NOD2) with Crohn’s disease1–3 has been a major breakthrough, illustrating the importance of disturbed innate immune function in the aetiology of chronic intestinal inflammation. Three main variants (R702W, G908R, and 1007fsInsC, originally labelled as single nucleotide polymorphisms 8, 12, and 13, respectively) in addition to a large number of private rare variants4 lead to incapacitation of the resulting NOD2 protein product.5–8 However, dissection of the main threads of NOD2 induced pathophysiology has resulted in controversial hypotheses.9,10 Unravelling the complex pathophysiology induced by expression of variant NOD2 proteins has therefore become one of the new challenges of clinical research in Crohn’s disease. NOD2 is expressed in various cell types, including intestinal epithelial cells,7,8 macrophages/monocytes, and B cells.6

Intestinal epithelial cells (IECs) have . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation?
S Buhner, C Buning, J Genschel, K Kling, D Herrmann, A Dignass, I Kuechler, S Krueger, H H-J Schmidt, and H Lochs
Gut 2006 55: 342-347. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs